Debt-to-equity of Pasithea Therapeutics Corp. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Pasithea Therapeutics Corp. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • Pasithea Therapeutics Corp. Debt-to-equity for the quarter ending 30 Sep 2025 was 11%, a 15% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Pasithea Therapeutics Corp. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 11% +1.5% +15% 30 Sep 2025
Q2 2025 9.2% -1% -9.9% 30 Jun 2025
Q1 2025 8.5% -0.86% -9.1% 31 Mar 2025
Q4 2024 8.9% +0.63% +7.6% 31 Dec 2024
Q3 2024 9.8% +2.6% +36% 30 Sep 2024
Q2 2024 10% +3.6% +54% 30 Jun 2024
Q1 2024 9.4% +3.9% +70% 31 Mar 2024
Q4 2023 8.3% +4% +93% 31 Dec 2023
Q3 2023 7.2% +3.5% +94% 30 Sep 2023
Q2 2023 6.7% +1.3% +24% 30 Jun 2023
Q1 2023 5.5% 31 Mar 2023
Q4 2022 4.3% 31 Dec 2022
Q3 2022 3.7% 30 Sep 2022
Q2 2022 5.4% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.